密固达治疗280例骨质疏松症的安全性分析
Safety observation of Aclasta in the treatment of 280 patients with primary osteoporosis
投稿时间:2013-07-23  
DOI:
中文关键词:  骨质疏松  密固达  预防性用药  不良反应
英文关键词:Primary osteoporosis  Aclasta  Preventive medication  Adverse reaction
基金项目:
作者单位E-mail
张菊 第二军医大学长海医院风湿免疫科,上海 200443  
徐霞   
赵东宝  zhaodongbao@medmail.com.cn 
童强   
摘要点击次数: 840
全文下载次数: 0
中文摘要:
      目的:探讨密固达治疗中出现不良反应的特点,对比几种不良反应预防性用药的疗效。方法回顾性分析密固达治疗280例骨质疏松症中出现不良反应的概率,对输液前使用地塞米松、乐松、泰诺预防抗过敏组与无药物预防组出现不良反应病例进行统计分析。结果180例预防用药组出现发热、肌肉酸痛、剧烈骨痛的概率明显低于100例非预防用药组,两组均未出现皮疹、肝肾功能损害。结论密固达不良反应以发热、肌肉酸痛流感症状为主,预防用药可明显减少流感症状,而对心律失常、眼部不良反应无显著性差异,几种预防用药组之间不良反应无显著性差异。
英文摘要:
      Objective To observe the adverse reaction of zoledronic acid, Aclasta, in the treatment of primary osteoporosis, and to compare the effect of different preventive medications.Methods A total of 280 patients with primary osteoporosis were selected.The enrolled patients were divided into 4 subgroups according to the preventive medication ( Dexamethasone, Loxonin, Tylenol, or no preventive medication) .The general condition and adverse reactions of all the patients were observed and analyzed. Results The main adverse reaction was fever, myosalgia, sever ostalgia, or cardiac arrhythmia.And the incidence of adverse reactions in 180 patients with preventive medications was much lower than that in 100 patients with no preventive medication.No patients had erythra or liver and kidney function damage.Conclusion The main adverse reactions of Aclasta were influenza-like symptoms, including fever and myosalgia.The preventive medication can significantly reduce the influenza-like symptoms, while it has no different effect on cardiac arrhythmia and the adverse reaction of the eye.There is no significant difference of the adverse reactions among the three subgroups with preventive medications.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=E462958F8A9B940E50706CEFF43DD50C12875E50826E59202C62705779EBD9A60703F7FFE0A3159CA72AB6B36FDDC883C80E1AAA00E6609CD4671D4970D85182FFF32F72A25A8C6489813A6D1CEC670425B0660CFF1F794EEE0EE575D972C0D3&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=9EAD63ADE6B277ED&aid=187DB8D3FE66742827BB610F320564CF&vid=&iid=5D311CA918CA9A03&sid=2BCD2FED7562E194&eid=72D13CE6C162BDF4&fileno=201408017&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="9EAD63ADE6B277ED"; var my_aid="187DB8D3FE66742827BB610F320564CF";